Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Follicular 7Lymphoma, B-Cell, Marginal Zone 7Breast Neoplasms 7Lymphoma, Non-Hodgkin 6Lymphoma, Mantle-Cell 6Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myeloid, Acute 5Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia 5Congenital Abnormalities 5Carcinoma, Ovarian Epithelial 5Waldenstrom Macroglobulinemia 4Lymphoma, Large-Cell, Immunoblastic 4Burkitt Lymphoma 4Myelodysplastic Syndromes 3Melanoma 3Lung Neoplasms 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Accelerated Phase 3Carcinoma, Non-Small-Cell Lung 3Blast Crisis 3Wilms Tumor 2Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Testicular Neoplasms 2Stomach Neoplasms 2Sezary Syndrome 2Recurrence 2Prostatic Neoplasms 2

Interventions

Rituximab 5Vorinostat 3Lenalidomide 3Irinotecan 3Filgrastim 3Dasatinib 3tanespimycin 2laromustine 2ixabepilone 2fludarabine phosphate 2entinostat 2belinostat 2Radiotherapy 2Paclitaxel 2Etoposide 2Cyclophosphamide 2Bortezomib 2Bevacizumab 2vandetanib 1tirbanibulin 1pyroxamide 1pomalidomide 1ontuxizumab 1obatoclax 1methoxyamine 1imetelstat 1ibrutinib 1etaracizumab 1dexamethasone acetate 1dexamethasone 21-phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Intraocular Lymphoma × Flow Cytometry × Clear all
NCT00720135 2015-06-08

Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma

City of Hope Medical Center

Phase 1 Completed
9 enrolled
Lymphoid

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡